Please enable JavaScript to continue using this application.

Compare $ACHV vs $VSTM | Chartloom

Compare

$ACHV vs $VSTM

Achieve Life Sciences Inc · Verastem Inc

ACHV

Achieve Life Sciences Inc

VSTM

Verastem Inc

Compare $ACHV vs $VSTM

Comparing Achieve Life Sciences Inc and Verastem Inc

ACHVAchieve Life Sciences Inc

VSTMVerastem Inc

ACHVAchieve Life Sciences Inc

Market cap

$761M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-89.3%

YTD performance

49.1%

52W performance

114.8%

FCF yield

-6.2%

VSTMVerastem Inc

Market cap

$736M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.92x

Rev growth (TTM)

3995.7%

YTD performance

15.9%

52W performance

-6.3%

FCF yield

-23.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACHV

VSTM

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

VSTM

Verastem Inc

Market Cap

ACHV$761M

VSTM$736M

Enterprise Value

ACHV$728M

VSTM$682M

Price

ACHV$7.41

VSTM$8.38

P/E Ratio

ACHVN/A

VSTMN/A

P/S Ratio

ACHV41.81x

VSTM8.41x

EV/Sales

ACHV39.95x

VSTM7.79x

EV/EBITDA

ACHV0.00x

VSTM0.00x

P/B Ratio

ACHV69.77x

VSTM14.07x

P/FCF Ratio

ACHVN/A

VSTMN/A

EV/FCF

ACHV-15.41x

VSTM-3.97x

PEG Ratio

ACHVN/A

VSTMN/A

Forward P/E (NTM)

ACHVN/A

VSTMN/A

Forward P/S (NTM)

ACHVN/A

VSTM4.92x

Revenue (TTM)

ACHV$0

VSTM$88M

Revenue Growth (YoY)

ACHV-89.3%

VSTM3995.7%

Forward Rev Growth

ACHV281.2%

VSTM61.6%

Gross Margin (TTM)

ACHV0.0%

VSTM87.6%

Operating Margin (TTM)

ACHV0.0%

VSTM0.0%

EBITDA Margin (TTM)

ACHV0.0%

VSTM-181.3%

Net Margin (TTM)

ACHV0.0%

VSTM-231.6%

FCF Margin (TTM)

ACHVN/A

VSTM-196.3%

Net Income (TTM)

ACHV$-114M

VSTM$-203M

FCF (TTM)

ACHV$-47M

VSTM$-172M

EPS (TTM)

ACHV-$1.22

VSTM-$2.02

ROE (TTM)

ACHV-19349.0%

VSTM-16540.0%

ROA (TTM)

ACHV-14373.0%

VSTM-9454.0%

ROIC (TTM)

ACHV-13245.0%

VSTM-7104.0%

Cash

ACHV$48M

VSTM$136M

Debt

ACHV$15M

VSTM$82M

Net Cash/Debt

ACHV$33M

VSTM$55M

Current Ratio (TTM)

ACHV0.95x

VSTM2.25x

Quick Ratio (TTM)

ACHV0.95x

VSTM2.12x

Debt/Equity (TTM)

ACHV1.40x

VSTM1.63x

Debt/Assets (TTM)

ACHV0.0%

VSTM0.0%

Interest Coverage (TTM)

ACHVN/A

VSTMN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

VSTM0.00x

Beta

ACHV2.44

VSTM0.58

52W Performance

ACHV114.8%

VSTM-6.3%

YTD Performance

ACHV49.1%

VSTM15.9%

% from 52W High

ACHV-14.2%

VSTM-22.6%

% from 52W Low

ACHV182.8%

VSTM144.3%

Asset Turnover (TTM)

ACHV0.33x

VSTM0.41x

FCF Yield (TTM)

ACHV-6.2%

VSTM-23.3%

Earnings Yield (TTM)

ACHV-15.0%

VSTM-27.5%

Dividend Yield (TTM)

ACHVN/A

VSTMN/A

Rule of 40

ACHV-89.3

VSTM3,799.4

EV/GP/RG

ACHVN/A

VSTM0.13

Ticker research

View ACHV research View VSTM research

Metric	ACHV Achieve Life Sciences Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$761M	$736M
Enterprise Value	$728M	$682M
Price	$7.41	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	8.41x
EV/Sales	39.95x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	-89.3%	3995.7%
Forward Rev Growth	281.2%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-114M	$-203M
FCF (TTM)	$-47M	$-172M
EPS (TTM)	-$1.22	-$2.02
ROE (TTM)	-19349.0%	-16540.0%
ROA (TTM)	-14373.0%	-9454.0%
ROIC (TTM)	-13245.0%	-7104.0%
Financial Health
Cash	$48M	$136M
Debt	$15M	$82M
Net Cash/Debt	$33M	$55M
Current Ratio (TTM)	0.95x	2.25x
Quick Ratio (TTM)	0.95x	2.12x
Debt/Equity (TTM)	1.40x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	0.58
52W Performance	114.8%	-6.3%
YTD Performance	49.1%	15.9%
% from 52W High	-14.2%	-22.6%
% from 52W Low	182.8%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.41x
FCF Yield (TTM)	-6.2%	-23.3%
Earnings Yield (TTM)	-15.0%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View ACHV research	View VSTM research

Valuation

P/S Ratio

VSTM

8.41x

ACHV

41.81x

EV/FCF

ACHV

-15.41x

VSTM

-3.97x

Growth & revenue

Revenue Growth TTM

VSTM

3995.7%

ACHV

-89.3%

Forward Revenue Growth

ACHV

281.2%

VSTM

61.6%

Profitability & performance

Gross Margin

VSTM

87.6%

ACHV

0.0%

ROE

VSTM

-16540.0%

ACHV

-19349.0%

FCF Yield %

ACHV

-6.2%

VSTM

-23.3%

52-Week Performance

ACHV

114.8%

VSTM

-6.3%

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

VSTM

Verastem Inc

Market Cap

ACHV$761M

VSTM$736M

Enterprise Value

ACHV$728M

VSTM$682M

Price

ACHV$7.41

VSTM$8.38

P/E Ratio

ACHVN/A

VSTMN/A

P/S Ratio

ACHV41.81x

VSTM8.41x

EV/Sales

ACHV39.95x

VSTM7.79x

EV/EBITDA

ACHV0.00x

VSTM0.00x

P/B Ratio

ACHV69.77x

VSTM14.07x

P/FCF Ratio

ACHVN/A

VSTMN/A

EV/FCF

ACHV-15.41x

VSTM-3.97x

PEG Ratio

ACHVN/A

VSTMN/A

Forward P/E (NTM)

ACHVN/A

VSTMN/A

Forward P/S (NTM)

ACHVN/A

VSTM4.92x

Revenue (TTM)

ACHV$0

VSTM$88M

Revenue Growth (YoY)

ACHV-89.3%

VSTM3995.7%

Forward Rev Growth

ACHV281.2%

VSTM61.6%

Gross Margin (TTM)

ACHV0.0%

VSTM87.6%

Operating Margin (TTM)

ACHV0.0%

VSTM0.0%

EBITDA Margin (TTM)

ACHV0.0%

VSTM-181.3%

Net Margin (TTM)

ACHV0.0%

VSTM-231.6%

FCF Margin (TTM)

ACHVN/A

VSTM-196.3%

Net Income (TTM)

ACHV$-114M

VSTM$-203M

FCF (TTM)

ACHV$-47M

VSTM$-172M

EPS (TTM)

ACHV-$1.22

VSTM-$2.02

ROE (TTM)

ACHV-19349.0%

VSTM-16540.0%

ROA (TTM)

ACHV-14373.0%

VSTM-9454.0%

ROIC (TTM)

ACHV-13245.0%

VSTM-7104.0%

Cash

ACHV$48M

VSTM$136M

Debt

ACHV$15M

VSTM$82M

Net Cash/Debt

ACHV$33M

VSTM$55M

Current Ratio (TTM)

ACHV0.95x

VSTM2.25x

Quick Ratio (TTM)

ACHV0.95x

VSTM2.12x

Debt/Equity (TTM)

ACHV1.40x

VSTM1.63x

Debt/Assets (TTM)

ACHV0.0%

VSTM0.0%

Interest Coverage (TTM)

ACHVN/A

VSTMN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

VSTM0.00x

Beta

ACHV2.44

VSTM0.58

52W Performance

ACHV114.8%

VSTM-6.3%

YTD Performance

ACHV49.1%

VSTM15.9%

% from 52W High

ACHV-14.2%

VSTM-22.6%

% from 52W Low

ACHV182.8%

VSTM144.3%

Asset Turnover (TTM)

ACHV0.33x

VSTM0.41x

FCF Yield (TTM)

ACHV-6.2%

VSTM-23.3%

Earnings Yield (TTM)

ACHV-15.0%

VSTM-27.5%

Dividend Yield (TTM)

ACHVN/A

VSTMN/A

Rule of 40

ACHV-89.3

VSTM3,799.4

EV/GP/RG

ACHVN/A

VSTM0.13

Ticker research

View ACHV research View VSTM research

Metric	ACHV Achieve Life Sciences Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$761M	$736M
Enterprise Value	$728M	$682M
Price	$7.41	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	8.41x
EV/Sales	39.95x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	-89.3%	3995.7%
Forward Rev Growth	281.2%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-114M	$-203M
FCF (TTM)	$-47M	$-172M
EPS (TTM)	-$1.22	-$2.02
ROE (TTM)	-19349.0%	-16540.0%
ROA (TTM)	-14373.0%	-9454.0%
ROIC (TTM)	-13245.0%	-7104.0%
Financial Health
Cash	$48M	$136M
Debt	$15M	$82M
Net Cash/Debt	$33M	$55M
Current Ratio (TTM)	0.95x	2.25x
Quick Ratio (TTM)	0.95x	2.12x
Debt/Equity (TTM)	1.40x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	0.58
52W Performance	114.8%	-6.3%
YTD Performance	49.1%	15.9%
% from 52W High	-14.2%	-22.6%
% from 52W Low	182.8%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.41x
FCF Yield (TTM)	-6.2%	-23.3%
Earnings Yield (TTM)	-15.0%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View ACHV research	View VSTM research